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Introduction: Vertical transmission of Trypanosoma cruzi infection accounts for a growing 
proportion of new cases of Chagas disease. Congenital Chagas disease is curable if treated 
promptly, but the majority of infected infants do not receive timely diagnosis or treatment. Better 
risk stratification is needed to predict which women are more likely to have and transmit the 
infection. 
 
Methods: This study enrolled women and their infants at the Percy Boland Women’s Hospital in 
Santa Cruz, Bolivia. Pregnant women were screened for T. cruzi by serological rapid test. Infants 
of seropositive mothers underwent diagnostic testing with microscopy (“micromethod”) and 
quantitative polymerase chain reaction (qPCR) as newborns and at one- and nine-month follow-
up. 
 
Results: Among 5,828 enrolled women, 1,271 (21.8%) were seropositive for Chagas disease. Of 
the 1,325 total infants of seropositive mothers, 113 infants (8.5%) were diagnosed with 
congenital Chagas disease by microscopy or qPCR. In a multivariate logistic regression, older 
maternal age, family history of Chagas disease, lack of maternal high school education, and 
multiple environmental factors were significantly associated with higher odds of maternal 
Chagas disease. Cesarean delivery was found to be protective against vertical transmission, 
adjusted for twin delivery (adjusted OR: 0.63, 95% CI: 0.41-0.98, p=0.040). Among infants born 
to mothers with Chagas disease, congenital infection was more common in twins (adjusted OR: 
 iii 
3.30, 95% CI: 1.97-5.54, p<0.001) and male infants (adjusted OR: 1.50, 95% CI: 1.01-1.22, 
p=0.045). 
 
Discussion: A better understanding of risk factors for maternal and congenital Chagas disease 
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Almost 6 million people worldwide are infected with Trypanosoma cruzi, the protozoan 
parasite that causes Chagas disease.1 A neglected tropical disease, Chagas disease is endemic to 
21 countries in Latin America and is a major source of morbidity and mortality in this region.2 
Bolivia has the highest prevalence of Chagas disease in the world, with over 6% of the overall 
population estimated to be infected with T. cruzi.1 In a 2013 analysis, Chagas disease was 
associated with an annual global burden of over 800,000 disability-adjusted life years (DALYs) 
and $600 million (USD) in health care costs.3 Chagas disease continues to grow as a global 
public health issue due to widespread migration. 
The majority of new cases with T. cruzi occur through vector-borne transmission by the 
triatomine bug (also known as the “kissing” bug).4,5 When the triatomine bug bites a human, 
feces infected with T. cruzi inoculates the skin or mucosa. Transmission may also occur through 
vertical transmission from mother to infant, blood transfusion, or consumption of contaminated 
food.6 Since the 1990’s, regional initiatives for the prevention of Chagas disease have 
significantly reduced vector-borne and blood-borne transmission rates.7 As a result, congenital 
infection has become an increasingly important source of transmission and now accounts for 
22% of new cases.8 
Vertical transmission occurs in approximately 5% of chronically infected mothers.8 
Transmission rates vary widely between studies but appear to be higher in endemic settings, 
which may be related to higher parasitemia, different strains of T. cruzi, or falsely inflated rates 
due to vector transmission in infants. Multigenerational transmission of Chagas disease has also 
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been reported, as congenitally infected females eventually pass the infection to their own 
infants.9–11 A small subset of congenitally infected infants presents with severe disease 
characterized by respiratory insufficiency, meningoencephalitis, hepatosplenomegaly, or 
anemia.8,12 However, the majority of infants are asymptomatic or have nonspecific symptoms, 
and thus rely on appropriate testing for diagnosis.12 Regardless of initial presentation, infants 
with congenital infection are presumed to have up to a 30% risk of potentially fatal 
cardiomyopathy or gastrointestinal disease later in life. 
Potentially curative treatment exists for acute T. cruzi infection, including therapy with 
benznidazole or nifurtimox. Because treatment is most effective and best tolerated in the first 
months of life, accurate screening in high-risk newborns is critical.13 In most endemic countries, 
the diagnostic algorithm for congenital infection relies on serological screening in the mother 
and microscopy, or “micromethod,” in the infant. Micromethod, which involves examination of 
peripheral blood for parasites, detects less than half of congenital infections.14–16 More sensitive 
diagnostics exist, such as quantitative polymerase chain reaction (qPCR), but these techniques 
are often unavailable in endemic settings due to the need for expensive imported equipment and 
technician expertise.13 Consequently, the majority of infants with congenital Chagas disease do 
not receive timely diagnosis or treatment in many endemic settings.16,17 
 Given the low rates of diagnosis and treatment of congenital Chagas disease despite the 
availability of treatment, better risk stratification is needed to predict which women are more 
likely to transmit the infection. Currently, our understanding of the risk factors for vertical 
transmission of T. cruzi infection is limited. Various maternal, epidemiological, and parasitic 
factors have been implicated in risk of transmission, but studies have often produced conflicting 
results.7,16,18 
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This study aims to describe the epidemiology of congenital Chagas disease in an endemic 
setting at the Percy Boland Women’s Hospital in Santa Cruz, Bolivia. The largest city in Bolivia, 
Santa Cruz has an estimated T. cruzi prevalence of 20-30% among pregnant women.16,17 This 
study also aims to identify demographic, medical, socioeconomic, and environmental risk factors 
for maternal Chagas disease and vertical transmission of T. cruzi infection. 
 
Materials and Methods: 
 
Setting and participants: 
The study took place at Percy Boland Women’s Hospital in Santa Cruz, Bolivia, which 
delivers approximately 8,000 infants each year. Mothers were eligible if they presented for 
delivery at the Percy Boland Women’s Hospital and gave informed consent. Mothers under the 
age of 18 were allowed to participate if they were emancipated minors, defined as married or 
living independently from their parents. Mothers gave informed consent for themselves and their 
newborns. The consent process was conducted by local investigators and trained study nurses. 
 
Maternal and infant data: 
Study personnel conducted a brief survey with participating mothers about medical 
history, obstetric history, and sociodemographic characteristics. Sociodemographic data included 
age, place of birth, address, highest attained education level, and profession. Data on the 
participants’ most recent delivery were obtained from the written patient medical record. Survey 
responses were recorded by study personnel using secure pre-programmed cell phones. 
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Participating women received perinatal screening for Chagas disease through a finger-
prick rapid test (InBios Chagas DetectTM Plus; reported sensitivity: 96.2%, reported specificity: 
98.8%).19 Women with a positive rapid test underwent confirmatory serologic testing with 
indirect hemagglutination (IHA, Wiener lab IHA Chagatest) or enzyme-linked immunosorbent 
assays (ELISA) with recombinant antigens (Wiener lab BioELISA Chagatest). In accordance 
with World Health Organization (WHO) guidelines, positive results from two separate 
immunoassays were required for a diagnosis of Chagas disease.19 
Infants of mothers with a positive Chagas disease rapid test were enrolled in the cohort 
(Figure 1). Testing included perinatal microscopic examination for T. cruzi organisms in 
peripheral blood (“micromethod”) and qPCR performed perinatally and at one- and nine-month 
follow-up. Among infants whose mother was seropositive for T. cruzi infection with 
confirmatory serology, a positive micromethod or qPCR within the first year of life was 
considered diagnostic for congenital Chagas disease. 
All maternal serological testing and neonatal micromethod were performed onsite in the 
maternity hospital’s laboratory. DNA extraction from blood samples and qPCR testing for T. 
cruzi were performed at the Infectious Diseases Research Laboratory of the Universidad Peruana 
Cayetano Heredia in Lima, Peru. Duplex real-time qPCR was performed targeting the T. cruzi 
nuclear genome satellite sequence and a recombinant plasmid (pZErO-2) as internal 
amplification control (IAC), according to published methods.20 Cycling conditions were 10 
minutes at 95°C, amplification at 95°C for 15 seconds and 58°C for one minute for 40 cycles, 
and extension at 72°C for one minute followed by a 4°C hold. 
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Mothers whose infants were diagnosed with congenital Chagas disease by either 
micromethod or qPCR were contacted by study personnel and referred for treatment of the infant 
with benznidazole, according to the national guidelines of the Chagas Program in Bolivia. 
This protocol was approved by the ethics committee of the Bolivian Catholic University, 
international registration FWA 0017928 and PRISMA 00001219. Study analysis was approved 
by the IRB at the University of North Carolina at Chapel Hill (IRB 19-3014). 
 
Statistical analysis: 
Data were analyzed using Stata (version 16). We calculated descriptive statistics of the 
overall population and stratified by maternal rapid test result. We performed univariate and 
multivariate logistic regressions to examine predictors of maternal infection with T. cruzi. We 
considered 22 variables as potential covariates (Table 2). We excluded previous diagnosis and 
treatment of Chagas disease from the final model due to potential collinearity. We set an a priori 
cutoff of 5% missing data to exclude other variables from the final model. We also set an a priori 
alpha criterion of 0.05 to remove variables that were not statistically contributing to the model 
and were thus subsequently removed from the model. Collinear variables (VIF approaching 10) 
were removed from the final model. We used the likelihood ratio test to determine if the reduced 
model was significantly different from the fully adjusted model using an alpha criterion of 0.05. 
We subsequently performed univariate and multivariate logistic regressions to examine 
maternal predictors of congenital infection with T. cruzi (Table 3). Only infants of mothers with 
confirmed serology for Chagas disease were included in this analysis. We considered the same 
variables as above, as well as having a Cesarean delivery, premature rupture of membranes 
(PROM), or twin birth. We set an a priori alpha criterion of 0.05 to remove variables that were 
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not statistically contributing to the model and were thus subsequently removed from the model. 
We used the likelihood ratio test to determine if the reduced model was significantly different 
from the fully adjusted model using an alpha criterion of 0.05. 
We also separately examined two infant risk factors for congenital Chagas disease, being 
a twin and sex (Table 4). We performed individual univariate logistic regressions and a 




From May 2016 to 2019, 5,828 pregnant women were enrolled (Figure 1). A total of 
5,643 singleton births, 181 twin births, and 4 triplet births resulted in a total of 6,017 infants 
delivered, including live births and stillbirths. 
The average age of enrolled women was 27.6 years old (SD: 7.3). Among enrolled 
women, 1,287 had a positive Chagas rapid test. Of these, 1,271 (98.8% of women with a positive 
rapid test; 22.0% of all enrolled women) had positive confirmatory serology with IHA or ELISA. 
Of the 1,325 infants whose mothers were seropositive for Chagas disease, 113 total 
infants (8.5% of infants with seropositive mothers, 1.9% overall) were diagnosed with congenital 
infection by micromethod or qPCR (Table 1). Of these, 87 infants (77.0%) were diagnosed by 
micromethod as newborns. An additional 26 infants (23.0%) with negative micromethod were 
subsequently diagnosed with qPCR during newborn or one-month testing. Of the 1,325 infants 
with seropositive mothers, only 272 (20.5%) returned for nine-month follow-up with qPCR 
testing. No new diagnoses were made through qPCR results at nine months. 
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Risk Factors for Maternal Infection: 
 A total of 20 risk factors were found to be significantly predictive of maternal infection 
with T. cruzi in the univariate analysis (Table 2). Demographic factors associated with higher 
odds of maternal infection included older maternal age and parity. Medical factors associated 
with higher odds of maternal infection included previous diagnosis of Chagas disease, previous 
treatment for Chagas disease, family history of Chagas disease, history of receiving donated 
blood, diagnosis of diabetes mellitus, positive maternal VDRL, and positive maternal 
toxoplasmosis. Socioeconomic factors associated with lower odds of maternal infection included 
maternal high school education (versus no high school education), paternal high school 
education, maternal career as a technician or professional (versus a career as a homemaker, 
laborer, service industry worker, or other), paternal career as a technician or professional, 
number of bedrooms in the home, and number of household amenities. Environmental factors 
associated with higher odds of maternal infection included having seen triatomine bugs in the 
home, having ever lived in a home with mud walls, having ever lived in a home with a roof made 
of palm, straw or hollow reeds, having ever lived in a home with a dirt floor, or having ever lived 
in a rural area. The number of people living in the home and number of rooms in the home were 
not significantly associated with odds of maternal infection (p=0.955 and p=0.073, respectively). 
A total of seven risk factors were found to be significantly predictive of maternal 
infection with T. cruzi in the final multivariate analysis (Table 2). Risk factors associated with 
higher odds of maternal infection included older maternal age (adjusted OR: 1.04, 95% CI: 1.03-
1.05, p<0.001), positive family history of Chagas disease (adjusted OR: 3.18, 95% CI: 2.75-3.67, 
p<0.001), having seen triatomine bugs in the home (adjusted OR: 3.49, 95% CI: 2.88-4.23, 
p<0.001), having ever lived in a home with mud walls (adjusted OR: 1.64, 95% CI: 1.26-2.12, 
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p<0.001), and having ever lived in a home with a dirt floor (adjusted OR: 1.83, 95% CI: 1.42-
2.36, p<0.001). Protective factors associated with lower odds of maternal infection included 
maternal high school education (adjusted OR: 0.65, 95% CI: 0.55-0.75, p<0.001) and having 
ever lived in a rural area (adjusted OR: 0.70, 95% CI: 0.58-0.84, p<0.001). Combined, these risk 
factors accounted for 20.9% of the variance in maternal infection status. 
VDRL and toxoplasmosis results were excluded from the final model because they 
exceeded our a priori limit of 5% missing data. Parity and number of home amenities were 
removed from the model due to collinearity. We determined that the other variables were not 
significant covariates due to an alpha criterion greater than 0.05; we confirmed that our final, 
reduced model was not significantly different than our fully adjusted model using the likelihood-
ratio test. 
 
Maternal Risk Factors for Vertical Transmission: 
Among seropositive mothers, two risk factors were found to be independently, 
significantly predictive of vertical transmission of T. cruzi infection in the univariate analysis: 
previous maternal diagnosis of Chagas disease and having a twin birth (Table 3). 
Two risk factors were found to be significantly predictive of vertical transmission in 
seropositive mothers in the final multivariate analysis. Having a Cesarean section rather than 
other forms of delivery was found to be a protective factor (adjusted OR: 0.63, 95% CI: 0.41-
0.98, p=0.040). Having twins rather than a singleton birth was a significant risk factor for 
vertical transmission (adjusted OR: 3.17, 95% CI: 1.53-6.55, p=0.002). Combined, these factors 
accounted for 1.6% of the total variance in vertical transmission. 
 9 
Previous maternal diagnosis of Chagas disease was not adapted into a multivariate model 
due to potential collinearity. We determined that the other variables were not significant 
covariates due to an alpha criterion greater than 0.05. 
 
Infant Risk Factors for Congenital Infection: 
 Among infants born to seropositive mothers, being a twin was independently, 
significantly associated with higher odds of vertical transmission of T. cruzi in the univariate 
analysis (OR: 3.25, 95% CI: 1.94-5.44, p<0.001) (Table 4). In the multivariate analysis, being a 
twin (adjusted OR: 3.30, 95% CI: 1.97-5.54, p<0.001) and male (adjusted OR: 1.50, 95% CI: 
1.01-2.22, p=0.045) were associated with higher odds of congenital Chagas disease (Table 3). 
Combined, these risk factors accounted for 2.7% of the total variance in infant infection status. 
 
Discussion: 
 At a maternity hospital in Santa Cruz, Bolivia, our study yielded a T. cruzi 
seroprevalence of 21.8% among pregnant women and a vertical transmission rate of 8.5%. This 
seroprevalence is somewhat lower than in the most recent Chagas cohort study in Santa Cruz, 
which demonstrated a 26% prevalence from 2010-2014.21 This difference could be explained by 
gradual community-wide reductions in Chagas disease due to regional vector control initiatives, 
as well differences between hospital populations or maternal rapid test techniques. The vertical 
transmission rate in our study is similar to the previous study, which demonstrated a 7.8% 
transmission rate. 
 Our study identified several risk factors for maternal Chagas disease, which combined 
accounted for approximately 20% of variation in disease status. Older maternal age was 
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independently associated with higher odds of maternal infection. This is consistent with findings 
from past studies and may be related to housing improvements and vector control initiatives, 
which have reduced seroprevalence of T. cruzi infection over time in many communities.22–27 
Family history of Chagas disease was also independently associated with higher odds of 
maternal infection, which may reflect environmental risk factors or multigenerational vertical 
transmission. Notably, pregnant women with a high school education had significantly lower 
odds of Chagas disease than women without a high school education. This result confirms the 
findings of several previous studies and highlights the importance of socioeconomic inequalities 
in maternal risk for Chagas disease.22,24,25 
 In the univariate analysis, maternal history of blood transfusion, diabetes mellitus, 
positive VDRL, and positive toxoplasmosis were associated with higher odds of infection. 
However, blood transfusion and diabetes mellitus were not significantly associated with maternal 
infection when adjusted for other variables in the multivariate analysis. VDRL and 
toxoplasmosis status were not included in the multivariate model due to the high percentage of 
missing data. Future studies may wish to examine whether VDRL and toxoplasmosis are 
independent risk factors for maternal infection. 
 Housing materials are an established risk factor for Chagas disease, as triatomine vectors 
thrive in houses with mud walls and thatched roofs.28 Our study found that history of living in a 
home with mud walls or dirt floor or having seen triatomine bugs in the home were 
independently associated with higher odds of maternal infection. Interestingly, although history 
of living in a rural area was associated with higher odds of maternal infection in the univariate 
analysis, it was a protective factor in the multivariate analysis. Although rural dwelling has 
previously been shown to be a risk factor for infection, it may be a proxy for poor housing 
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construction, lower educational levels, or triatomine infestations. Rural dwelling may not be an 
independent risk factor for infection when adjusted for these factors. The reasons for rural 
dwelling being protective against infection are unclear but could be related to immune tolerance 
or increased awareness of vector transmission. This would be consistent with findings that 
prolonged or high levels of vector exposure, such as living in a triatomine-infested house, are 
associated with reduced risk of vertical transmission.29–32 
 Our study also identified maternal and infant risk factors for vertical transmission, which 
combined accounted for a small amount of variance in infant disease status. Notably, Cesarean 
section was associated with lower odds of vertical transmission when controlled for twin births. 
To our knowledge, this is the first study investigating the association of birth type with risk of 
vertical transmission of T. cruzi. Because the multivariate analysis only included delivery type 
and twin birth, it is unclear whether the association with Cesarean section could be related to 
socioeconomic factors. This question warrants additional research, as Cesarean section has been 
shown to be protective against vertical transmission of certain infectious diseases, such as human 
immunodeficiency virus (HIV).33 Twins and male infants also had significantly higher odds of 
congenital Chagas disease. The association between twins and risk of vertical transmission has 
demonstrated in two previous studies and may be related to placental insufficiency or enhanced 
immune suppression.29,34 The association between infant sex and risk of transmission has only 
been evaluated in a handful of studies, with conflicting results.21,32,35 Future studies are needed to 
examine whether sex-based hormonal or genetic differences contribute to susceptibility to 
vertical transmission. 
Our study has several limitations. First, diagnosis of congenital Chagas disease relied 
primarily on perinatal and one-month microscopy and qPCR, as the majority of infants did not 
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complete nine-month follow-up (Figure 1). In addition, due to loss to follow-up and laboratory 
closures due to COVID-19, we did not have access to nine-month serology results, which are 
considered the gold standard for congenital Chagas disease diagnosis.21 As a result, many cases 
of vertical transmission were likely missed. Unfortunately, low follow-up rates are common in 
congenital Chagas disease cohort studies in endemic, low-resource setting.16,21,36 Barriers to 
follow-up include perceived low risk to infants and the cost of travel to the hospital, particularly 
for families living in remote, impoverished areas. Our study is also limited by its reliance on self-




 Overall, our cohort study in a high-burden, low-resource setting in Santa Cruz, Bolivia 
adds to a growing body of literature of risk factors for maternal Chagas disease and vertical 
transmission to infants. Our findings suggest that older age, family history of Chagas disease, 
educational level, and environmental exposures contribute to maternal risk of Chagas disease. It 
also suggests that Cesarean delivery may be protective against vertical transmission, while twins 
and male infants may have increased risk of infection. Future studies are needed to validate these 
findings and consider additional predictors of vertical transmission, as the risk factors in our 
study contributed to a small proportion of overall variance. A better understanding of risk factors 
for vertical transmission of T. cruzi infection may improve risk stratification in high-risk 






1.  Chagas disease in Latin America: an epidemiological update based on 2010 estimates. 
Wkly Epidemiol Rec. 2015;90(6):33-43. 
2.  Pérez-Molina JA, Molina I. Chagas disease. Lancet. 2018;391(10115):82-94. 
doi:10.1016/S0140-6736(17)31612-4 
3.  Lee BY, Bacon KM, Bottazzi ME, Hotez PJ. Global economic burden of Chagas disease: 
A computational simulation model. Lancet Infect Dis. 2013;13(4):342-348. 
doi:10.1016/S1473-3099(13)70002-1 
4.  Franco-Paredes C, Von A, Hidron A, et al. Chagas disease: An impediment in achieving 
the Millennium Development Goals in Latin America. BMC Int Health Hum Rights. 
2007;7:7. doi:10.1186/1472-698X-7-7 
5.  Caryn Bern. Chagas’ Disease. N Engl J Med. 2015;373:456-466. 
6.  Bern C. Chagas’ disease. N Engl J Med. 2015;373(5):456-466. 
doi:10.1056/NEJMra1410150 
7.  Cevallos AM, Hernández R. Chagas’ disease: Pregnancy and congenital transmission. 
Biomed Res Int. 2014;2014. doi:10.1155/2014/401864 
8.  Howard EJ, Xiong X, Carlier Y, Sosa-Estani S, Buekens P. Frequency of the congenital 
transmission of Trypanosoma cruzi: A systematic review and meta-analysis. BJOG An Int 
J Obstet Gynaecol. 2014;121(1):22-33. doi:10.1111/1471-0528.12396 
9.  Raimundo SM, Massad E, Yang HM. Modelling congenital transmission of Chagas’ 
disease. BioSystems. 2010;99(3):215-222. doi:10.1016/j.biosystems.2009.11.005 
10.  Schenone H, Gaggero M, Sapunar J, Contreras MDC, Rojas A. Congenital Chagas disease 
 14 
of second generation in Santiago, Chile. Report of two cases. Rev Inst Med Trop Sao 
Paulo. 2001;43(4):231-232. doi:10.1590/S0036-46652001000400011 
11.  Carlier Y, Truyens C. Maternal-fetal transmission of Trypanosoma cruzi. In: American 
Trypanosomiasis Chagas Disease: One Hundred Years of Research: Second Edition. 
Elsevier Inc.; 2017:517-559. doi:10.1016/B978-0-12-801029-7.00024-1 
12.  Bern C, Martin DL, Gilman RH. Acute and Congenital Chagas Disease. In: Advances in 
Parasitology. Vol 75. Academic Press; 2011:19-47. doi:10.1016/B978-0-12-385863-
4.00002-2 
13.  Picado A, Cruz I, Redard-Jacot M, et al. The burden of congenital Chagas disease and 
implementation of molecular diagnostic tools in Latin America. BMJ Glob Heal. 
2018;3(5):e001069. doi:10.1136/bmjgh-2018-001069 
14.  Messenger LA, Bern C. Congenital Chagas disease: current diagnostics, limitations and 
future perspectives. Curr Opin Infect Dis. 2018;31(5):415-421. 
doi:10.1097/QCO.0000000000000478 
15.  Mora MC, Sanchez Negrette O, Marco D, et al. Early diagnosis of congenital 
Trypanosoma cruzi infection using PCR, hemoculture, and capillary concentration, as 
compared with delayed serology. J Parasitol. 2005;91(6):1468-1473. doi:10.1645/GE-
549R.1 
16.  Bern C, Verastegui M, Gilman RH, et al.  Congenital Trypanosoma cruzi Transmission in 
Santa Cruz, Bolivia . Clin Infect Dis. 2009;49(11):1667-1674. doi:10.1086/648070 
17.  Alonso-Vega C, Billot C, Torrico F. Achievements and Challenges upon the 
Implementation of a Program for National Control of Congenital Chagas in Bolivia: 
Results 2004-2009. PLoS Negl Trop Dis. 2013;7(7). doi:10.1371/journal.pntd.0002304 
 15 
18.  Gebrekristos HT, Buekens P. Mother-to-child transmission of Trypanosoma cruzi. J 
Pediatric Infect Dis Soc. 2014;3(SUPPL1). doi:10.1093/jpids/piu059 
19.  Shah V, Ferrufino L, Gilman RH, et al. Field evaluation of the InBios Chagas detect plus 
rapid test in serum and whole-blood specimens in Bolivia. Clin Vaccine Immunol. 
2014;21(12):1645-1649. doi:10.1128/CVI.00609-14 
20.  Mayta H, Romero YK, Pando A, et al. Improved DNA extraction technique from clot for 
the diagnosis of Chagas disease. PLoS Negl Trop Dis. 2019;13(1):e0007024. 
doi:10.1371/journal.pntd.0007024 
21.  Messenger LA, Gilman RH, Verastegui M, et al. Toward Improving Early Diagnosis of 
Congenital Chagas Disease in an Endemic Setting. Clin Infect Dis. 2017;65(2):268-275. 
doi:10.1093/cid/cix277 
22.  Cucunubá ZM, Flórez AC, Cárdenas Á, et al. Prevalence and risk factors for chagas 
disease in pregnant women in Casanare, Colombia. Am J Trop Med Hyg. 2012;87(5):837-
842. doi:10.4269/ajtmh.2012.12-0086 
23.  Hidron AI, Gilman RH, Justiniano J, et al. Chagas cardiomyopathy in the context of the 
chronic disease transition. PLoS Negl Trop Dis. 2010;4(5). 
doi:10.1371/journal.pntd.0000688 
24.  Sasagawa E, Aiga H, Corado EY, et al. Risk factors for Chagas disease among pregnant 
women in El Salvador. Trop Med Int Heal. 2015;20(3):268-276. doi:10.1111/tmi.12440 
25.  Castellanos-Domínguez YZ, Cucunubá ZM, Orozco LC, et al. Risk factors associated 
with Chagas disease in pregnant women in Santander, a highly endemic Colombian area. 
Trop Med Int Heal. 2016;21(1):140-148. doi:10.1111/tmi.12634 
26.  Brutus L, Castillo H, Bernal C, et al. Short Report: Detectable Trypanosoma cruzi 
 16 
Parasitemia during Pregnancy and Delivery as a Risk Factor for Congenital Chagas 
Disease. Am J Trop Med Hyg. 2010;83(5):1044-1047. doi:10.4269/ajtmh.2010.10-0326 
27.  Samuels AM, Clark EH, Galdos-Cardenas G, et al. Epidemiology of and Impact of 
Insecticide Spraying on Chagas Disease in Communities in the Bolivian Chaco. PLoS 
Negl Trop Dis. 2013;7(8). doi:10.1371/journal.pntd.0002358 
28.  Bern C. Chagas’ Disease. Longo DL, ed. N Engl J Med. 2015;373(5):456-466. 
doi:10.1056/NEJMra1410150 
29.  Kaplinski M, Jois M, Galdos-Cardenas G, et al. Sustained Domestic Vector Exposure Is 
Associated With Increased Chagas Cardiomyopathy Risk but Decreased Parasitemia and 
Congenital Transmission Risk Among Young Women in Bolivia. Clin Infect Dis. 
2015;61(6):918-926. doi:10.1093/cid/civ446 
30.  Rendell VR, Gilman RH, Valencia E, et al. Trypanosoma cruzi-infected pregnant women 
without vector exposure have higher parasitemia levels: Implications for congenital 
transmission risk. PLoS One. 2015;10(3):e0119527. doi:10.1371/journal.pone.0119527 
31.  Martin Suasnabar S, Veronica Olivera L, Laura Bizai M, Elizabeth Arias E, Denner S, 
Lucrecia Fabbro D. Maternal Risk Factors for the Transmission of Congenital Chagas 
Disease. Rev Patol Trop. 2018;47(3):133. doi:10.5216/rpt.v47i3.55252 
32.  Negrette OS, Mora MC, Basombrío MÁ. High prevalence of congenital Trypanosoma 
cruzi infection and family clustering in Salta, Argentina. Pediatrics. 2005;115(6):e668-72. 
doi:10.1542/peds.2004-1732 
33.  Andiman W, Boucher M, Burns D, et al. The mode of delivery and the risk of vertical 
transmission of human immunodeficiency virus type 1: A meta-analysis of 15 prospective 
cohort studies. N Engl J Med. 1999;340(13):977-987. 
 17 
doi:10.1056/NEJM199904013401301 
34.  Rendell VR, Gilman RH, Valencia E, et al. Trypanosoma cruzi-infected pregnant women 
without vector exposure have higher parasitemia levels: Implications for congenital 
transmission risk. PLoS One. 2015;10(3):e0119527. doi:10.1371/journal.pone.0119527 
35.  Salas NA, Cot M, Schneider D, et al. Risk factors and consequences of congenital Chagas 
disease in Yacuiba, south Bolivia. Trop Med Int Heal. 2007;12(12):1498-1505. 
doi:10.1111/j.1365-3156.2007.01958.x 
36.  Alonso-Vega C, Hermann E, Truyens C, et al. Immunological status of mothers infected 
with Trypanosoma cruzi. Rev Soc Bras Med Trop. 2005;38 Suppl 2:101-104. 
37.  Carlier Y, Torrico F, Sosa-Estani S, et al. Congenital chagas disease: Recommendations 
for diagnosis, treatment and control of newborns, siblings and pregnant women. PLoS 
Negl Trop Dis. 2011;5(10). doi:10.1371/journal.pntd.0001250 
38.  Wells G, Shea B, O’Connell D, et al. The Newcastle-Ottawa Scale (NOS) for assessing 
the quality of nonrandomised studies in meta-analysis. 
http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp. Accessed April 13, 2020. 
39.  Basile L, Ciruela P, Requena-Méndez A, et al. Epidemiology of congenital chagas disease 
6 years after implementation of a public health surveillance system, Catalonia, 2010 to 
2015. Eurosurveillance. 2019;24(26). doi:10.2807/1560-7917.ES.2019.24.26.19-00011 
40.  Herrera C, Truyens C, Dumonteil E, et al. Phylogenetic Analysis of Trypanosoma cruzi 
from Pregnant Women and Newborns from Argentina, Honduras, and Mexico Suggests an 
Association of Parasite Haplotypes with Congenital Transmission of the Parasite. J Mol 
Diagnostics. 2019;21(6):1095-1105. doi:10.1016/j.jmoldx.2019.07.004 
41.  Juiz NA, Cayo NM, Burgos M, et al. Human Polymorphisms in Placentally Expressed 
 18 
Genes and Their Association With Susceptibility to Congenital Trypanosoma cruzi 
Infection. J Infect Dis. 2016;213(8):1299-1306. doi:10.1093/infdis/jiv561 
42.  Murcia L, Carrilero B, Munoz-Davila MJ, Thomas MC, López MC, Segovia M. Risk 
factors and primary prevention of congenital Chagas disease in a nonendemic country. 
Clin Infect Dis. 2013;56(4):496-502. doi:10.1093/cid/cis910 
43.  Bern C, Montgomery SP. An Estimate of the Burden of Chagas Disease in the United 
States. Clin Infect Dis. 2009;49(5):e52-4. doi:10.1086/605091 
44.  Alonso-Vega C, Billot C, Torrico F. Achievements and Challenges upon the 
Implementation of a Program for National Control of Congenital Chagas in Bolivia: 
Results 2004-2009. PLoS Negl Trop Dis. 2013;7(7):e2304. 
doi:10.1371/journal.pntd.0002304 
45.  Hermann E, Truyens C, Alonso‐Vega C, et al.  Congenital Transmission of Trypanosoma 
cruzi Is Associated with Maternal Enhanced Parasitemia and Decreased Production of 
Interferon‐γ in Response to Parasite Antigens . J Infect Dis. 2004;189(7):1274-1281. 
doi:10.1086/382511 
46.  Scapellato PG, Bottaro EG, Rodríguez-Brieschke MT. Mother-child transmission of 
Chagas disease: Could coinfection with human immunodeficiency virus increase the risk? 
Rev Soc Bras Med Trop. 2009;42(2):107-109. doi:10.1590/S0037-86822009000200002 
47.  Chaparro RM, Genero S. Transmisión congénita y factores maternos de la enfermedad de 
Chagas en niños al nacer y sus hermanos en la provincia del Chaco, Argentina. Rev Fac 
Cienc Med Cordoba. 2018;75(4):279. doi:10.31053/1853.0605.v75.n4.21260 
48.  Volta BJ, Bustos PL, Cardoni RL, De Rissio AM, Laucella SA, Bua J.  Serum Cytokines 
as Biomarkers of Early Trypanosoma cruzi infection by Congenital Exposure . J Immunol. 
 19 
2016;196(11):4596-4602. doi:10.4049/jimmunol.1502504 
49.  Burgos JM, Altcheh J, Bisio M, et al. Direct molecular profiling of minicircle signatures 
and lineages of Trypanosoma cruzi bloodstream populations causing congenital Chagas 



































* Maternal Chagas disease was diagnosed by positive rapid test followed by confirmatory testing 
with IHA or ELISA 
† 3 infants whose mother was serologically positive for T. cruzi received micromethod testing 
but had inconclusive results due to laboratory error. None of these infants had a subsequent 
positive qPCR test result. 
‡ Of these infants, 16 had at least one negative qPCR during follow-up. The remainder (n=32) 








6,017 total infants 
(5,828 total mothers)
1,325 (22.0%) infants of mothers with 
Chagas disease 
(1,271 mothers with Chagas disease*) 
87 (6.6%) infants with 
positive micromethod 
1,238 (93.4%) infants with negative 
or inconclusive† micromethod 
1,212 (97.9%) 
negative or 
incomplete qPCR  
26 (2.1%) 
positive qPCR  
48 (55.2%) negative 
or incomplete qPCR‡ 
39 (44.8%) 
positive qPCR  
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Table 1. Summary of diagnostic results among infants of seropositive mothers 





qPCR positive (n) 39 26 65 
qPCR negative or 
incomplete* (n) 
48 1,212 1,260 




















Table 2. Maternal demographics and risk factors for chronic Chagas disease 
 















Age 27.6  7.3 24.5  6.9 1.06 (1.05-1.07) 1.04 (1.03-1.05) 
Parity 3.3 ± 1.8 2.7  1.7 1.19 (1.15-1.23) - 
Medical history 
Previous diagnosis of 
Chagas disease 
780 (61.4%) 171 (3.8%) 40.7 (33.7-49.3) -* 
Previous treatment for 
Chagas disease 
38 (3.0%) 11 (0.2%) 12.7 (6.5-25.0) -* 
Family history of 
Chagas disease 
746 (58.7%) 1264 (27.7%) 3.70 (3.25-4.21) 3.18 (2.75-3.67) 
History of receiving 
donated blood 
196 (15.4%) 502 (11.0%) 1.47 (1.23-1.76) - 
Diabetes mellitus 18 (1.4%) 36 (0.8%) 1.80 (1.02-3.19) - 
VDRL† 
    Positive (reference) 
    Negative 










3.34 (1.47-7.60) - 
Toxoplasmosis † 
    Positive (reference) 
    Negative 










2.19 (1.15-4.15) - 
Socioeconomic factors 
Maternal high school 
education 
   Yes (reference) 
    No 

















Paternal high school 
education 
   Yes (reference) 
    No 













0.68 (0.60-0.77) - 
Maternal career 
    Professional or technician 
(reference) 
    Other ‡ 














Paternal career    - 
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    Professional or technician 
(reference) 
    Other ‡ 










Number of people living 
in home 
5.7  2.6 5.7  2.9 1.00 (0.98-1.02) - 
Number of bedrooms in 
home 
2.3  1.4 2.4  1.5 0.95 (0.91-0.99) - 
Number of total rooms 
in home 
4.3  1.8 4.4  1.9 0.97 (0.94-1.00) - 
Number of household 
amenities 
3.0  0.9 3.1  0.9 0.86 (0.80-0.92) - 
Environmental factors 
Having seen triatomine 
bugs in the home 
740 (58.2%) 780 (17.1%) 6.75 (5.89-7.73) 3.49 (2.88-4.23) 
Having lived in a home 
with mud walls 
714 (56.2%) 859 (18.9%) 5.52 (4.83-6.31) 1.64 (1.26-2.12) 
Having lived in a home 
with a roof made of 
palm, straw, or hollow 
reeds 
530 (41.7%) 594 (13.0%) 4.78 (4.14-5.49) - 
Having lived in a home 
with a dirt floor 
673 (53.0%) 772 (16.9%) 5.52 (4.82-6.31) 1.83 (1.42-2.36) 
Having lived in a rural 
area 
834 (65.6%) 2009 (44.1%) 2.42 (2.13-2.76) 0.70 (0.58-0.84) 
 
Variables not significantly contributing to the multivariate model were removed from the final 
reduced model (see Methods). Home amenities included electricity, television, refrigerator, 
personal form of transportation, and computer. 
In the final multivariate model, odds ratios were adjusted for all other variables found to 
significantly contribute to the model: age, family history of Chagas disease, maternal high school 
education, having seen triatomine bugs in the home, having lived in a home with mud walls, 
having lived in a home with a dirt floor, and having lived in a rural area.  
*Excluded from multivariate model (see Methods) 
†Independent variables with >5% missing data 






Table 3. Maternal demographics and risk factors for vertical transmission of T. cruzi 
infection 
 


















Age 27.8  7.3 27.5  7.3 1.00 (0.98-1.03) - 
Parity 3.4  1.8 3.2  1.8 1.04 (0.93-1.16) - 
Medical history 
Previous diagnosis of 
Chagas disease 85 (84.2%) 695 (59.4%) 3.63 (2.10-6.27) -* 
Previous treatment 
for Chagas disease 
4 34 1.38 (0.48-3.96) -* 
Family history of 
Chagas disease 52 694 0.73 (0.48-1.09) - 
History of receiving 
donated blood 12 184 0.72 (0.39-1.35) - 
Diabetes mellitus 0 (0%) 18 1 - 
VDRL † 
    Positive (reference) 
    Negative 









3.74 (0.97-14.5) - 
Toxoplasmosis † 
    Positive (reference) 
    Negative 









1.04 (0.06-17.6) - 
Socioeconomic factors 
Maternal high school 
education 
    Yes (reference) 
    No 











0.71 (0.44-1.13) - 
Paternal high school 
education 
    Yes (reference) 
    No 











0.83 (0.54-1.27) - 




1.44 (0.63-3.25) - 
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    Professional or 
technician (reference) 
    Other ‡ 








    Professional or 
technician (reference) 
    Other ‡ 











1.43 (0.93-2.20) - 
Number of people 
living in household 6.0  2.5 5.6  2.7 1.04 (0.97-1.12) - 
Number of bedrooms 
in home 2.4  1.8 2.3  1.4 1.08 (0.94-1.23) - 
Number of total 
rooms in home 4.4  2.1 4.3  1.8 1.03 (0.92-1.15) - 
Number of 
household amenities 3.0  0.9 3.0  0.9 1.08 (0.86-1.37) - 
Environmental factors 
Having seen 
triatomine bugs in 
the home 
63 (62.4%) 677 (57.9%) 1.21 (0.79-1.84) - 
Having lived in a 
home with mud 
walls 
54 (53.5%) 660 (56.4%) 0.89 (0.59-1.33) - 
Having lived in a 
home with a roof 
made of palm, straw, 
or hollow reeds 
46 (45.5%) 484 (41.4%) 1.19 (0.79-1.78) - 
Having lived in a 
home with a dirt 
floor 
50 (49.5%) 623 (53.2%) 0.86 (0.57-1.29) - 
Having lived in a 
rural area 
69 (68.3%) 765 (65.4%) 1.14 (0.74-1.77) - 
Pregnancy and delivery factors 
Cesarean delivery 67 (66.3%) 875 (74.8%) 0.66 (0.43-1.02) 0.63 (0.41-0.98) 
Premature rupture of 
membranes 
8 (7.9%) 80 (6.8%) 1.17 (0.55-2.50) - 
Twin birth 10 (9.9%) 42 (3.6%) 2.95 (1.43-6.08) 3.17 (1.53-6.55) 
Variables not significantly contributing to the multivariate model were removed from the final 
reduced model (see Methods). 
In the final multivariate model, odds ratios were adjusted for all other variables found to 
significantly contribute to the model: Cesarean delivery and twin birth. 
* Excluded from multivariate model (see Methods) 
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† Independent variables with >5% missing data 












































Table 4. Infant demographics and risk factors for congenital Chagas disease in infants 
born to mothers with Chagas disease 










Being a twin 22 (19.5%) 84 (6.9%) 3.25 (1.94-5.44) 3.30 (1.97-5.54) 







































Appendix 1. Limited Systematic Review 
Introduction 
 Over 5 million people in Latin America are infected with Trypanosoma cruzi, the 
parasitic agent of Chagas disease.1 Although transmission most commonly occurs through the 
triatomine vector (“kissing bug”), vertical transmission from mother to infant accounts for over 
20% of new cases.8 Congenitally infected infants, like other individuals with Chagas disease, 
have up to a 30% lifetime risk of developing severe and potentially fatal sequelae such as 
cardiomyopathy, arrhythmias, and gastrointestinal complications.12 
 Antiparasitic therapy is available for T. cruzi infection, and congenital Chagas disease is 
nearly always curable in the first year of life.13 Likelihood of cure and tolerability of therapy 
wane with age. However, the majority of infants with congenital Chagas disease do not receive 
timely diagnosis and treatment. Infant diagnosis is complex, costly, and may take up to a year, as 
serology cannot be reliably performed until maternal antibody disappears after eight months.37 
Given the limited resources in many endemic setting, better risk stratification is needed to 
identify maternal, environmental, and sociodemographic characteristics associated with higher 
rates of vertical transmission. 
In this limited systematic review, we aim to identify factors associated with an increased 
risk of vertical transmission of T. cruzi infection. Specifically, we compare characteristics of 
cases in which women with chronic Chagas disease did transmit the infection to their infants to 






 Searches were performed for relevant literature in PubMed, LILACS, and Embase 
electronic databases (Figure A1-1, Table A1-1). A search was also performed in 
clinicaltrials.gov to identify ongoing or unpublished studies. The last search was performed on 
March 20, 2020. There was not a registered protocol. 
  
Study Selection 
Studies from the aforementioned searches were compiled for further review in 
Covidence, which removed duplicate studies. One reviewer screened studies by title and abstract 
using eligibility criteria determined a priori (Table A1-2) and removed irrelevant studies. Studies 
of mothers with confirmed serology for T. cruzi infection and their infants were included. 
Acceptable exposures included a broad array of potential risk factors for T. cruzi transmission, 
including maternal, parasite, and infant characteristics. Previous maternal treatment for Chagas 
disease or known infant sequelae of congenital Chagas disease were not considered risk factors. 
We included studies that compared these exposures among women who did or did not transmit T. 
cruzi infection, or among infants of seropositive women who did or did not develop congenital 
Chagas disease. We included infants diagnosed with congenital Chagas disease within one year 
of delivery, as serological diagnosis cannot be performed until after eight months of age, when 
maternal antibody has disappeared.37 Infant T. cruzi infections diagnosed after one year were 
excluded as these could represent new acute infections. We included empirical interventional or 
observational study designs including randomized controlled trials, cohort studies, case control 
studies, or cross-sectional studies. Review articles, single-patient case studies, letters and 
comments were excluded. No studies were excluded based on language, date of publication, 
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publication status, country of origin, or clinical setting. Following title and abstract review, full 
text articles were screened for inclusion using the same eligibility criteria. 
 
Study Assessment 
 Risk of bias in individual studies was assessed using the Newcastle-Ottawa Scale (NOS), 
an accepted quality rating tool for observational studies (Table A1-3).38 This scale evaluates 
study quality using a total of eight categories which reflect the selection, comparability, and 
outcomes of each study. Studies were evaluated by a single reviewer. 
 
Data Extraction 
 Data extracted for each study included setting, population, study design, Chagas disease 
prevalence and congenital transmission rate, and risk factors examined (Table A1-4). Study data 
were extracted manually by a single reviewer. Meta-analysis was not performed given the 




The search identified a total of 549 publications (Figure A1-1). The publications 
underwent screening by title and abstract, and 493 were determined to be irrelevant. The 
remaining 56 were screened with full text review. Studies were excluded for ineligible 
publication type (reviews, single case studies, letters or comments), outcome of interest (did not 
compare vertical transmission to no vertical transmission), full text unavailable, duplicate, 
ineligible study design (for example, irrelevant control group), being an ongoing trial with no 
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study results, ineligible exposure (for example, previous maternal treatment for Chagas disease), 
or being a poor-quality study (for example, not describing methods for maternal or infant 
diagnosis of T. cruzi infection).  
 
Study Characteristics and Findings 
The final analysis included 19 publications, of which two were in Spanish. Study 
participants were drawn primarily from Bolivia (nine studies) and Argentina (eight studies). 
Other participant countries included Spain, Mexico, Honduras, and Paraguay.39–42 The included 
publications examined a wide variety of potential risk factors for vertical transmission, including 
maternal age, parasitic load, parasite and infant genetics, having twins, immunologic factors, 
vector exposure, and more. Individual study designs and findings are summarized in Table A1-4, 
and key results organized by risk factor are summarized in Table A1-5. 
Several studies examined maternal parasitic load as a risk factor for vertical transmission 
of T. cruzi infection. Four studies found a significant association between higher maternal 
parasitic load and risk of vertical transmission, and no studies reported a non-significant or 
reduced risk with higher parasitic load.26,29,34,43 In addition, several studies found an increased 
risk of vertical transmission among mothers with positive T. cruzi PCR, culture, serology, or 
xenodiagnosis during pregnancy, which may also be suggestive of higher parasitic load.35,42–46 
Maternal vector exposure also appeared to influence risk of vertical transmission. Four studies 
found that significant historical exposure to triatomine bugs was associated with lower risk of 
vertical transmission, and two studies found that current home exposure to triatomine bugs was 
not associated with vertical transmission risk.29,31,32,34,47 
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Other potential risk factors examined by multiple studies included maternal age, having 
twins, socioeconomic factors, and immunologic factors. In seven studies reporting on risk by 
maternal age, maternal age was not significantly associated with risk of vertical transmission in 
six studies.31,32,34,35,39,43 Only one study found a higher vertical transmission rate among younger 
women.21 In three studies assessing risk of vertical transmission among twin births, two found an 
increased risk of vertical transmission and one found no significant difference.29,34,35 Two studies 
found no difference in risk among mothers who lived in urban or rural areas.31,47 Three studies 
examined a variety of maternal and infant immunologic factors.17,45,48 For example, two studies 
found higher risk of vertical transmission among women with higher IFN-γ levels in cord blood 
and whole blood cells incubated with T. cruzi lysate, respectively.17,45 Finally, several individual 
studies considered additional risk factors, such as infant and parasite genetics, maternal HIV 
status, infant sex, and maternal clinical form of Chagas disease.21,39–41,46 
 
Risk of Bias 
 The risk of bias in the included publications ranged from moderate to high, assessed by 
the Newcastle-Ottawa Scale (Table A1-3). The most common limitation was inadequate follow-
up or response rates, as the majority of infants did not complete the nine-month follow-up 
required for serological diagnosis. Another common source of potential bias was limited 
comparability between study groups. The majority of included publications did not control for 




 This study is the first systematic review to examine and assess risk factors for vertical 
transmission of Chagas disease. We identified 19 relevant publications with significant 
heterogeneity in study design, population, and exposures. 
The strongest body of evidence supports an increased risk of vertical transmission among 
mothers with higher parasitic load. As trypanocidal therapy is contraindicated in pregnant 
women, this finding suggests that reducing parasitic load in women of childbearing age prior to 
pregnancy may be a target for reducing vertical transmission. Notably, several studies also found 
higher transmission rates among women with lower vector exposure.29,31,32,34 Although 
somewhat counterintuitive, this relationship is likely explained by differences in parasitic load. 
Previous studies have found that women who live in infested homes for extended periods 
actually have lower parasitic loads, leading to the hypothesis that continued re-exposure or 
superinfection primes the immune system for an enhanced response.34 
Although older age is a known risk factor for Chagas disease in many endemic countries, 
six of seven studies that examined maternal age found it was not a significant risk factor for 
vertical transmission. In addition, some studies suggested that twin births and immunologic 
factors may play a role in risk of vertical transmission. Maternal immunologic response to T. 
cruzi infection, such as IFN-γ production, may affect susceptibility to vertical transmission; it is 
unclear whether this susceptibility is mediated by parasitic load. Twin births could also be more 
susceptible to congenital infection due to placental insufficiency or enhanced immune 
suppression. More research is warranted to clarify whether twins have an increased risk of 
vertical transmission, and if so, to study the pathogenesis of this risk. 
This limited systematic review has several limitations, including the scope and quality of 
the existing literature. Common limitations in the studies included lack of comparability between 
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study groups, lack of control for potential confounding factors, and high loss to follow-up. Poor 
follow-up is a frequent challenge for congenital Chagas disease studies as infant diagnosis can 
take up to nine months for serological results.16,21,36 Many families do not return for long-term 
follow-up due to financial and travel barriers and low perceived benefit. This study is also 
limited by the use of a single reviewer to select and evaluate studies. 
 
Conclusions 
 Despite the high morbidity and mortality associated with congenital Chagas disease, 
relatively few studies have examined risk factors for vertical transmission of T. cruzi infection. 
Our current understanding of these risk factors is limited by poor to moderate quality evidence 
and a lack of prospective, randomized trials. However, the existing literature suggests that high 
maternal parasitic load is associated with elevated risk of vertical transmission of T. cruzi, while 
maternal age does not appear contributory. Additional high-quality research is needed to further 
elucidate maternal, environmental, infant, and parasitic risk factors for vertical transmission and 
to identify high-risk populations. As the literature continues to grow, another systematic review 

































Table A1-1. Search terms 
Database Search Terms Results (n) Date Searched 
PubMed ("Chagas Disease"[Mesh] OR chagas OR chagas*) 
AND (vertical* OR congenital*) AND (risk[tw] 
OR risks[tw] OR risk factors[mesh] OR driver[tw] 
OR drivers[tw] OR determinant*[tw] OR predict* 
OR indicat* OR suscep*) 
299 3/20/20 
EMBASE (chagas OR chagasic) AND (vertical OR 
congenital) AND (risk OR risks OR driver OR 
drivers OR determinant OR predict OR predictor 
OR indicate OR indicator OR susceptible OR 
susceptibility) 
391 3/20/20 
LILACS (chagas OR chagasic) AND (vertical OR 
congenital) AND (risk OR risks OR driver OR 
drivers OR determinant OR predict OR predictor 
OR indicate OR indicator OR susceptible OR 
susceptibility) 
54 3/20/20 
Clinicaltrials.gov (vertical OR congenital) AND (risk OR risks OR 
driver OR drivers OR determinant OR predict OR 
predictor OR indicate OR indicator OR susceptible 
















Table A1-2. Inclusion and exclusion criteria 
PICOTSS Inclusion criteria Exclusion criteria 
Population Mothers with chronic Chagas disease and 
their infants 
Mothers without confirmed 
serological diagnosis of T. 
cruzi infection 
Exposure Risk factors such as maternal or parasite 
genetics, parasitic load, living situation, 
socioeconomic status, maternal nutrition, 
etc. 
Known sequelae of congenital 
Chagas disease (such as low 
birth weight or respiratory 
distress) or previous maternal 
treatment for Chagas disease 
Comparison Lack of vertical transmission of T. cruzi 
infection from a serologically positive 
mother to her infant 
Other comparisons, such as 
infants of mothers without 
chronic Chagas disease  
Outcomes Vertical transmission of T. cruzi infection 
from a serologically positive mother to 
her infant 
 
Timing Diagnosis of congenital Chagas disease 
within 1 year of delivery 
Infant diagnosis after 1 year 
of age 
Setting Any country, medical setting, publication 
date, or language 
None 
Study type Empirical interventional or observational 
study designs including randomized 
controlled trials, cohort studies, case 
control studies, or cross-sectional studies 
Reviews, single-patient case 












Table A1-3. Risk of bias assessment using Newcastle-Ottawa Scale (NOS).38 Per NOS 
guidelines, a maximum of one star can be awarded for each selection or outcome category; a 
maximum of two stars can be awarded for the comparability category. Overall quality 
assessment was given as the total number of stars awarded, with a maximum of nine stars. 
 
Study 






ness of the 
exposed cohort 




t of exposure 
Demonstration 
that outcome 
of interest was 
not present at 
start of study 
Comparability 
of cohorts on the 
basis of the 
design or 
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Bern, 
200916 
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Brutus et 
al., 201026 







       5 
Murcia et 
al., 201342 
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Rendell et 
al., 201534 
        6 
Salas et al., 
200735 
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Case control studies  
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Vega et al., 
200536 
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Hermann et 
al., 200445 
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Herrera et 
al., 201940 
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Juiz et al., 
201641 
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Volta et al., 
201648 




















Table A1-4. Evidence table of included studies. 
Study Setting Population Study Design Chagas Prevalence 
and Transmission 
Rates 














Cord blood cells of seropositive mothers who 
transmitted the infection had higher levels of 
IFN- and lower levels of IL-10 than those of 
seropositive mothers who did not transmit 
(79.427.8 vs. 26.110.3 pg/mL and 13.75.3 vs 
5.31.6 pg/mL, respectively) (no statistics 
provided). 
 
Mitogen-stimulated cord blood cells of 
seropositive mothers who transmitted the 
infection were less likely to produce IL-10 than 
those of seropositive mothers who did not 
transmit (35% vs. 7.60%) (no statistics provided). 
 
Seropositive mothers who transmitted T. cruzi 
infection were more likely to have a positive 
culture than seropositive mothers who did not 
(47% vs. 23%, p<0.05). 












2.8% transmission rate 
Mothers with other children with Chagas disease 
had higher odds of vertical transmission (OR: 
22.79, p=0.001, 95% CI: 3.75-161.54). 
 
Mothers with the cardiac form of Chagas disease 
had higher odds of vertical transmission (OR: 
14.40, p=0.009, 95% CI: 2.11-87.67) than 
mothers with the indeterminate form. 
 
Maternal age, previous treatment for Chagas 
disease, country of birth, and years living in 
Catalonia were not significantly associated with 
likelihood of vertical transmission (p=0.693, 
p=0.093, p=0.801, and p=0.453, respectively). 









29% seroprevalence in 
mothers 
 
6.5% transmission rate 
Mothers who transmitted T. cruzi infection had 
higher parasite load than mothers who did not 
(p<0.01). 
 
Mothers with a positive T. cruzi PCR result 
during pregnancy were more likely to transmit 
the infection (p=0.014). 
 
Maternal age and parity were not significantly 
associated with likelihood of vertical 
transmission (p=0.64 and p=0.41, respectively). 













Mothers with high parasite density had a higher 
risk of vertical transmission than those with low 
parasite density (p<0.001). 






Infants with congenital 
Chagas disease (n=47) 
and their mothers; 
unrelated seropositive 
pregnant women who 







There was no significant association between T. 
cruzi IId lineage and risk of vertical transmission 
(p>0.05). 
 
Among seropositive mothers, those with positive 
PCR were more likely to transmit (5/7, 71.4%) 









confirmed T. cruzi 
infection (n=247), 
their infants with 
suspected infection 






6.1% transmission rate 
Newborn health care (taking the infant to a local 
health center for congenital Chagas disease 
evaluation) was associated with reduced odds of 
congenital infection (adjusted OR: 0.21, 95% CI: 
0.05-0.82, p=0.02). Knowledge of the infection, 
rural residence in infancy, living in a home with 
mud walls, straw roof, or dirt floor, triatomine 
bugs in the home, blood transfusions, maternal 
diagnosis with T. cruzi infection, annual 
cardiology care, and household cohabitants were 
not associated with odds of congenital 
transmission. 
 
Number of siblings was associated with higher 
odds of congenital infection (adjusted OR: 1.89, 
95% CI: 1.43-2.49, p<0.001). 





Dates not provided 
Pregnant women with 
confirmed T. cruzi 
infection who did 
(n=24) and did not 
(n=35) transmit to 






More women who transmitted had a positive 
hemoculture than women who did not transmit 
(p<0.05). 
 
There were no significant differences in 
secretions of IL-2, IL-4, IL-10, or TGF-β1 
between mothers who did or did not transmit. 
 
Women who transmitted had higher levels of 
IFN-γ in whole blood cells incubated with T. 
cruzi lysate than women who did not transmit 
(p<0.01). 
 
Mothers who transmitted had lower proportions 
of CD4+ HLA-DR+ T lymphocytes than mothers 
who did not transmit (p<0.05). Proportions of 
CD4+ CD45RO+ T cells were similar between 
groups. 





Pregnant women with 
T. cruzi infection 








T. cruzi haplotypes differed between mothers 
who did and did not vertically transmit the 
infection (p=0.021). 











4.7% transmission rate 
Infant mutations in the SNPs in the ADAM12 
(rs11244787 and rs1871054) and MMP2 
(rs243866, rs17859821, and rs2285053) genes, 
which code for placental expression enzymes, 
were associated with higher odds of transmission. 
The C>T mutation in rs1871054 was associated 
with lower odds of transmission (adjusted OR 
0.401, 95% CI: 0.227-0.709, p=0.002). The A>G 
mutation in rs11244787 was associated with 
higher odds of transmission (adjusted OR 2.085, 
95% CI: 1.212-3.589, p=0.008). The A mutation 
was associated with higher odds of transmission 
in rs243866 (adjusted OR 49.61, 95% CI: 11.62-
211.8, p=0.0001) and rs17859821 (adjusted OR 
2.304, 95% CI: 1.301-4.08, p=0.004). The TT 
allelotype in rs2285053 was associated with 
higher odds of transmission (adjusted OR 4.903, 
95% CI: 1.017-23.65, p=0.048). 
Other SNPs in ALPP (rs2014683 and rs1048988), 
MMP2 (rs243865, rs243864, and rs2285053), and 
MMP9 (rs3919242 and rs2234681) were not 
associated with transmission. 
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Kaplinski et al., 
201529 











6.8% transmission rate 
Mothers who transmitted T. cruzi infection had 
higher parasite load than mothers who did not 
(p<0.0001). 
 
Transmission was higher in twin than singleton 
births (p=0.04). 
 
Mothers who had not lived in houses infected 
with triatomine bugs were more likely to transmit 
than those that had (p=0.04). 
Messenger et 
al., 201721 











7.8% transmission rate 
Mothers who transmitted T. cruzi infection were 
younger than mothers who did not (p<0.01). 
 
Female infants of seropositive mothers were more 
likely to be diagnosed with congenital Chagas 
disease than male infants (p<0.05). 














Seropositive mothers with a positive T. cruzi 
PCR result during pregnancy were more likely to 
transmit the infection to their infants than 
seropositive mothers with a negative PCR results 
(p=0.0046). 
Rendell et al., 
201534 













Congenital transmission was more common in 
twin births than singleton births (p=0.03). 
 
Congenital transmission occurred in 31.3%, 
15.4%, and 0% of women with high, moderate, 
and low parasite loads, respectively (χ2 for trend 
18.2, p<0.0001). 
 
Women who reported living in an infested house 
for 1-19 years or 20 or more years had lower odds 
of congenital transmission than women with 0 
years of living in an infected house (p=0.049). 
Living in an infested house or currently living in 
an infested house were not significantly 
associated with odds of congenital transmission 
(p=0.28 and p=0.46, respectively). 
 
Maternal age was not associated with odds of 
congenital transmission (p=0.92). 
 













5.1% transmission rate 
Among all mothers (with and without Chagas 
disease), positive maternal T. cruzi serology was 
associated with higher odds of transmission (OR: 
19.39, p<0.0001, 95% CI: 5.95-62.71). Positive 
maternal parasitemia was also associated with 
higher odds of transmission (OR: 11.62, 
p<0.0001, 95% CI: 5.92-22.82). 
 
Among all mothers (with and without Chagas 
disease), maternal age, parity, time of residence, 
being born in Yacuiba, living in a rural area, 
being without an insecticide house-spraying 
program, lack of antenatal visit, cesarean section, 
infant sex, hot season of delivery, and previous 
stillbirth were not significantly associated with 
odds of transmission (p>.05). 
 
Congenital transmission rate was not significantly 










Infants (n=340) born 





9.1% transmission rate 
Seropositive women from endemic regions with 
low vector control were less likely to transmit 
than seropositive women from endemic regions 
with high vector control (p=0.045). 
 
Maternal age, infant sex, and sibling order were 

















The transmission rate was higher among children 
born to HIV+ women (3/3, 100%) than children 
born to HIV- women (10/91, 10.9%) 







Women (n=83) and 
infants (n=237) with 







Maternal age and history of transfusion were not 
associated with risk of transmission (p=0.059 and 
0.605, respectively). 
 
Mothers with medium or high vector exposure 
had lower risk of transmission than mothers with 
no or low vector exposure (RR=0.36, 95% CI: 
0.14-0.97, p=0.046). 
 
Positive xenodiagnosis in seropositive mothers 
was a risk factor for transmission, controlled for 
maternal age, transfusion history, and vector 
exposure (RR=12, 95% CI: 2.9-50.1). 






Infants diagnosed with 
congenital Chagas 
disease diagnosed 
within 1 month (B+C1, 
n=15), 6 months 
(B+C2, n=10), or 12 
months (B+C3, n=10); 
randomly chosen 
uninfected infants born 
to seropositive mothers 
(B-M+, n=10); 
randomly chosen 
uninfected infants born 
to seronegative 
mothers (B-M-, n=10) 
Retrospective 
cohort study 
- Congenitally infected infants had higher plasma 
levels of IL-17A than uninfected infants of 
seropositive mothers (p<0.0001 for all subgroups 
at 1 month). 
 
Congenitally infected infants had higher plasma 
levels of MCP-1 than uninfected infants of 
seropositive mothers (p=0.0004 for B+C1, 
p=0.0343 for B+C2, p=0.0274 for B+C3 at 1 
month). 
 
Congenitally infected infants had higher plasma 
levels of monokine induced by IFN-γ than 
uninfected infants of seropositive mothers 
(p<0.0001 for B+C1, p=0.0021 for B+C2, 
p=0.0232 for B+C3 at 1 month). 
 
Congenitally infected infants had lower plasma 
levels of IFN-γ than uninfected infants of 
seropositive mothers (p<0.0001 for all subgroups 
at 1 month). 
 
Congenitally infected infants diagnosed after 6 
months had higher plasma levels of IL-6 
(p=0.0091 for B+C2, p=0.0184 for B+C3 at 6 
months) and IL-17F (p=0.0261 for B+C2, 
p=0.0399 for B+C3 at 6 months) than uninfected 






Table A1-5. Summary of evidence by risk factor 
*Statistics not provided in the original study for this association 
Risk factor 
Studies suggesting increased risk 
of vertical transmission 
Studies suggesting no difference in 
risk of vertical transmission 
Maternal age 
One study found an increased risk among 
younger mothers.21 
Several studies found no difference in risk 
with maternal age.16,30–32,35,39 
Maternal parity 
One study found an increased risk in infants 
with a larger number of siblings.47 
Two studies found no difference in risk with 
maternal parity.16,35 
Parasite load and 
diagnostics 
 
Several studies found an increased risk with 
parasite load,16,26,29,34 positive PCR,8,16*,17 
positive T. cruzi serology,35 parasitemia,35 
positive T. cruzi culture36,45 or positive 
xenodiagnoses during pregnancy.31 
 
Parasite genetics 
One study found apparent clustering of 
parasite sequences from congenital 
transmission cases in the TcII-TcV-TcVI 
cluster.40* 
One study found no difference in risk with 
T. cruzi IId lineage.49 
Infant genetics 
One study found an increased risk with 
infant mutations in SNPs of the ADAM12 
(rs11244787, rs1871054) and MMP2 
(rs243866, rs17859821, rs2285053) genes, 
which code for placental expression 
enzymes.41 
One study found no difference in risk with 
infant mutations in SNPs of the ALPP 
(rs2014683, rs1048988), MMP2 (rs243865, 
rs243864, rs2285053), and MMP9 
(rs3919242, rs2234681) genes.41 
Socioeconomic 
factors 
 Two studies found no difference in risk 
among women who lived in a rural area35 or 
lived in a rural area during infancy.47  
Twins and siblings 
Two studies found higher risk in twin than 
singleton births.29,30 
 
One study found an increased risk with 
having other siblings with Chagas.39 
One study found no difference in risk 
between twin and singleton births.35 
Immunologic factors 
One study found an increased risk among 
infants with higher IL-17A, higher MCP-1, 
higher monokine induced by IFN-γ, and 
lower IFN-γ.48 
 
One study found an increased risk among 
women whose cord blood had higher IFN-γ 
and lower IL-10.36* 
 
One study found increased risk among 
women with higher IFN-γ in whole blood 
cells incubated with T. cruzi lysate and 
women with lower proportions of CD4+ 
HLA-DR+ T lymphocytes.45 
One study found no difference in risk by 
maternal IL-2, IL-4, IL-10, or TGF-β1 
levels.45 
Maternal HIV status 
One study found an increased risk among 




Two studies found a higher risk among 
women who had never lived in a triatomine-
infested house than women who had.29,30 
 
One study found a higher risk among 
women with low or no vector exposure than 
women with medium or high vector 
exposure.31 
 
One study found a higher risk among 
women from endemic areas with high vector 
control than women from endemic areas 
with low vector control.32 
Two studies found no difference in risk 
between women who reported currently 
having triatomine bugs in the home and 
women who did not.30,47 
Infant sex 
One study found an increased risk among 
female infants.21 
Two studies found that infant sex was not a 
risk factor.32,35 
Other 
One study found increased risk with the 
maternal cardiac form of Chagas disease, 
compared to the indeterminate form.39 
 
Two studies found that maternal history of 
blood transfusion was not a risk factor.31,47 
 
One study found that sibling order was not a 
risk factor.32 
 
 
 
 
 
 
 
 
 
 
